Ave Talu

Ave Talu

Auto-generated profile, based on publicly available information

Ave Talu

Estonian Drug Monitoring Centre, National Institute for Health Development, Hiiu 42, 11619 Tallinn, Estonia

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2010 in International Journal of Drug Policy
Verified
Journal Article
Closed access
ATAve Talu
Ave Talu
KRKristiina Rajaleid
Kristiina Rajaleid
KAKatri Abel-Ollo
Katri Abel-Ollo
KRKristi Rüütel
Kristi Rüütel
MRMati Rahu
Mati Rahu
AUAnneli Uusküla
Anneli Uusküla

30 June 2011 in BMC Public Health
Verified
Journal Article
Open access
PDF file
AUAnneli Uusküla
Anneli Uusküla
DJDon C Des Jarlais
Don C Des Jarlais
MKMart Kals
Mart Kals
KRKristi Rüütel
Kristi Rüütel
KAKatri Abel-Ollo
Katri Abel-Ollo
ISIgor Sobolev
Igor Sobolev
Estonia has experienced an HIV epidemic among intravenous drug users (IDUs) with the highest per capita HIV prevalence in Eastern Europe. We assessed the effects of expanded syringe exchange programs (SEP) in the capital city, Tallinn, which has an estimated 10,000 IDUs.

1 January 2009 in Harm Reduction Journal
Verified
Journal Article
Open access
PDF file
SVSigrid Vorobjov
Sigrid Vorobjov
AUAnneli Uusküla
Anneli Uusküla
KAKatri Abel-Ollo
Katri Abel-Ollo
ATAve Talu
Ave Talu
KRKristi Rüütel
Kristi Rüütel
DJDon C Des Jarlais
Don C Des Jarlais
Both syringe exchange programs (SEPs) and pharmacy sales of syringes are available in Estonia, though the current high incidence and high prevalence of HIV among injection drug users (IDUs) in Tallinn, Estonia requires large-scale implementation of additional harm reduction programs as a matter of great urgency. The aims of this report were to compare risk behavior and HIV infection and to assess the prevention needs among IDUs who primarily use pharmacies as their source of sterile syringes with IDUs who primarily use SEPs in Tallinn.